Selected research
Market Structure
Global Sustained-release Medicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Sustained-release Medicine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Sustained-release Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Sustained-release Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Sustained-release Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Sustained-release Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Sustained-release Medicine include Zhuhai Rundu Pharmaceutical, Endo Pharmaceuticals, Takeda, Shanghai Shyndec Pharmaceutical, Sanofi, Johnson & Johnson, Novartis, Pfizer and China Res Double-Crane, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Sustained-release Medicine market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Sustained-release Medicine and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Sustained-release Medicine revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Sustained-release Medicine market size, projected growth trends, production technologies, key applications, and end-use industries.
Sustained-release Medicine Segment by Company
Zhuhai Rundu Pharmaceutical
Endo Pharmaceuticals
Takeda
Shanghai Shyndec Pharmaceutical
Sanofi
Johnson & Johnson
Novartis
Pfizer
China Res Double-Crane
Bayer
AbbVie
AstraZeneca
Collegium Pharmaceutical, Inc
Sustained-release Medicine Segment by Type
Original Ground Medicine
Generic Medicine
Sustained-release Medicine Segment by Application
Hospital
Drugstore
Other
Sustained-release Medicine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sustained-release Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sustained-release Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sustained-release Medicine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Sustained-release Medicine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Sustained-release Medicine industry.
Chapter 3: Detailed analysis of Sustained-release Medicine companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sustained-release Medicinerevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Original Ground Medicine
- Generic Medicine
Applications
- Hospital
- Drugstore
- Other
Companies covered
- Zhuhai Rundu Pharmaceutical
- Endo Pharmaceuticals
- Takeda
- Shanghai Shyndec Pharmaceutical
- Sanofi
- Johnson & Johnson
- Novartis
- Pfizer
- China Res Double-Crane
- Bayer
- AbbVie
- AstraZeneca
- Collegium Pharmaceutical, Inc
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Sustained-release Medicine Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Original Ground Medicine
- 1.2.3 Generic Medicine
- 1.3 Market Analysis by Application
- 1.3.1 Global Sustained-release Medicine Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Hospital
- 1.3.3 Drugstore
- 1.3.4 Other
- 1.4 Global Market Growth Prospects
- 1.5 Global Sustained-release Medicine Growth Trends by Region
- 1.5.1 Global Sustained-release Medicine Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Sustained-release Medicine Market Size by Region (2021-2026)
- 1.5.3 Sustained-release Medicine Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Sustained-release Medicine Market Dynamics
- 2.1 Sustained-release Medicine Industry Trends
- 2.2 Sustained-release Medicine Industry Drivers
- 2.3 Sustained-release Medicine Industry Opportunities and Challenges
- 2.4 Sustained-release Medicine Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Sustained-release Medicine Revenue by Company (2021-2026)
- 3.2 Global Sustained-release Medicine Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Sustained-release Medicine Key Company Head office and Area Served
- 3.4 Global Sustained-release Medicine Company, Product Type & Application
- 3.5 Global Sustained-release Medicine Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Sustained-release Medicine Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Sustained-release Medicine Players Market Share by Revenue in 2025
- 3.6.3 2025 Sustained-release Medicine Tier 1, Tier 2, and Tier 3
4 Sustained-release Medicine Market by Type
- 4.1 Global Sustained-release Medicine Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Sustained-release Medicine Market Size by Type (2021-2032)
- 4.3 Global Sustained-release Medicine Market Size Share by Type (2021-2032)
5 Sustained-release Medicine Market by Application
- 5.1 Global Sustained-release Medicine Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Sustained-release Medicine Market Size by Application (2021-2032)
- 5.3 Global Sustained-release Medicine Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Zhuhai Rundu Pharmaceutical
- 6.1.1 Zhuhai Rundu Pharmaceutical Company Information
- 6.1.2 Zhuhai Rundu Pharmaceutical Business Overview
- 6.1.3 Zhuhai Rundu Pharmaceutical Sustained-release Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Zhuhai Rundu Pharmaceutical Sustained-release Medicine Product Portfolio
- 6.1.5 Zhuhai Rundu Pharmaceutical Recent Developments
- 6.2 Endo Pharmaceuticals
- 6.2.1 Endo Pharmaceuticals Company Information
- 6.2.2 Endo Pharmaceuticals Business Overview
- 6.2.3 Endo Pharmaceuticals Sustained-release Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Endo Pharmaceuticals Sustained-release Medicine Product Portfolio
- 6.2.5 Endo Pharmaceuticals Recent Developments
- 6.3 Takeda
- 6.3.1 Takeda Company Information
- 6.3.2 Takeda Business Overview
- 6.3.3 Takeda Sustained-release Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Takeda Sustained-release Medicine Product Portfolio
- 6.3.5 Takeda Recent Developments
- 6.4 Shanghai Shyndec Pharmaceutical
- 6.4.1 Shanghai Shyndec Pharmaceutical Company Information
- 6.4.2 Shanghai Shyndec Pharmaceutical Business Overview
- 6.4.3 Shanghai Shyndec Pharmaceutical Sustained-release Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Shanghai Shyndec Pharmaceutical Sustained-release Medicine Product Portfolio
- 6.4.5 Shanghai Shyndec Pharmaceutical Recent Developments
- 6.5 Sanofi
- 6.5.1 Sanofi Company Information
- 6.5.2 Sanofi Business Overview
- 6.5.3 Sanofi Sustained-release Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Sanofi Sustained-release Medicine Product Portfolio
- 6.5.5 Sanofi Recent Developments
- 6.6 Johnson & Johnson
- 6.6.1 Johnson & Johnson Company Information
- 6.6.2 Johnson & Johnson Business Overview
- 6.6.3 Johnson & Johnson Sustained-release Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Johnson & Johnson Sustained-release Medicine Product Portfolio
- 6.6.5 Johnson & Johnson Recent Developments
- 6.7 Novartis
- 6.7.1 Novartis Company Information
- 6.7.2 Novartis Business Overview
- 6.7.3 Novartis Sustained-release Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Novartis Sustained-release Medicine Product Portfolio
- 6.7.5 Novartis Recent Developments
- 6.8 Pfizer
- 6.8.1 Pfizer Company Information
- 6.8.2 Pfizer Business Overview
- 6.8.3 Pfizer Sustained-release Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Pfizer Sustained-release Medicine Product Portfolio
- 6.8.5 Pfizer Recent Developments
- 6.9 China Res Double-Crane
- 6.9.1 China Res Double-Crane Company Information
- 6.9.2 China Res Double-Crane Business Overview
- 6.9.3 China Res Double-Crane Sustained-release Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 China Res Double-Crane Sustained-release Medicine Product Portfolio
- 6.9.5 China Res Double-Crane Recent Developments
- 6.10 Bayer
- 6.10.1 Bayer Company Information
- 6.10.2 Bayer Business Overview
- 6.10.3 Bayer Sustained-release Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Bayer Sustained-release Medicine Product Portfolio
- 6.10.5 Bayer Recent Developments
- 6.11 AbbVie
- 6.11.1 AbbVie Company Information
- 6.11.2 AbbVie Business Overview
- 6.11.3 AbbVie Sustained-release Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 AbbVie Sustained-release Medicine Product Portfolio
- 6.11.5 AbbVie Recent Developments
- 6.12 AstraZeneca
- 6.12.1 AstraZeneca Company Information
- 6.12.2 AstraZeneca Business Overview
- 6.12.3 AstraZeneca Sustained-release Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 AstraZeneca Sustained-release Medicine Product Portfolio
- 6.12.5 AstraZeneca Recent Developments
- 6.13 Collegium Pharmaceutical, Inc
- 6.13.1 Collegium Pharmaceutical, Inc Company Information
- 6.13.2 Collegium Pharmaceutical, Inc Business Overview
- 6.13.3 Collegium Pharmaceutical, Inc Sustained-release Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Collegium Pharmaceutical, Inc Sustained-release Medicine Product Portfolio
- 6.13.5 Collegium Pharmaceutical, Inc Recent Developments
7 North America
- 7.1 North America Sustained-release Medicine Market Size (2021-2032)
- 7.2 North America Sustained-release Medicine Market Size by Type
- 7.2.1 North America Sustained-release Medicine Market Size by Type (2021-2026)
- 7.2.2 North America Sustained-release Medicine Market Size by Type (2027-2032)
- 7.2.3 North America Sustained-release Medicine Market Share by Type (2021-2032)
- 7.3 North America Sustained-release Medicine Market Size by Application
- 7.3.1 North America Sustained-release Medicine Market Size by Application (2021-2026)
- 7.3.2 North America Sustained-release Medicine Market Size by Application (2027-2032)
- 7.3.3 North America Sustained-release Medicine Market Share by Application (2021-2032)
- 7.4 North America Sustained-release Medicine Market Size by Country
- 7.4.1 North America Sustained-release Medicine Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Sustained-release Medicine Market Size by Country (2021-2026)
- 7.4.3 North America Sustained-release Medicine Market Size by Country (2027-2032)
- 7.4.4 North America Sustained-release Medicine Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Sustained-release Medicine Market Size (2021-2032)
- 8.2 Europe Sustained-release Medicine Market Size by Type
- 8.2.1 Europe Sustained-release Medicine Market Size by Type (2021-2026)
- 8.2.2 Europe Sustained-release Medicine Market Size by Type (2027-2032)
- 8.2.3 Europe Sustained-release Medicine Market Share by Type (2021-2032)
- 8.3 Europe Sustained-release Medicine Market Size by Application
- 8.3.1 Europe Sustained-release Medicine Market Size by Application (2021-2026)
- 8.3.2 Europe Sustained-release Medicine Market Size by Application (2027-2032)
- 8.3.3 Europe Sustained-release Medicine Market Share by Application (2021-2032)
- 8.4 Europe Sustained-release Medicine Market Size by Country
- 8.4.1 Europe Sustained-release Medicine Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Sustained-release Medicine Market Size by Country (2021-2026)
- 8.4.3 Europe Sustained-release Medicine Market Size by Country (2027-2032)
- 8.4.4 Europe Sustained-release Medicine Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Sustained-release Medicine Market Size (2021-2032)
- 9.2 China Sustained-release Medicine Market Size by Type
- 9.2.1 China Sustained-release Medicine Market Size by Type (2021-2026)
- 9.2.2 China Sustained-release Medicine Market Size by Type (2027-2032)
- 9.2.3 China Sustained-release Medicine Market Share by Type (2021-2032)
- 9.3 China Sustained-release Medicine Market Size by Application
- 9.3.1 China Sustained-release Medicine Market Size by Application (2021-2026)
- 9.3.2 China Sustained-release Medicine Market Size by Application (2027-2032)
- 9.3.3 China Sustained-release Medicine Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Sustained-release Medicine Market Size (2021-2032)
- 10.2 Asia Sustained-release Medicine Market Size by Type
- 10.2.1 Asia Sustained-release Medicine Market Size by Type (2021-2026)
- 10.2.2 Asia Sustained-release Medicine Market Size by Type (2027-2032)
- 10.2.3 Asia Sustained-release Medicine Market Share by Type (2021-2032)
- 10.3 Asia Sustained-release Medicine Market Size by Application
- 10.3.1 Asia Sustained-release Medicine Market Size by Application (2021-2026)
- 10.3.2 Asia Sustained-release Medicine Market Size by Application (2027-2032)
- 10.3.3 Asia Sustained-release Medicine Market Share by Application (2021-2032)
- 10.4 Asia Sustained-release Medicine Market Size by Country
- 10.4.1 Asia Sustained-release Medicine Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Sustained-release Medicine Market Size by Country (2021-2026)
- 10.4.3 Asia Sustained-release Medicine Market Size by Country (2027-2032)
- 10.4.4 Asia Sustained-release Medicine Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Sustained-release Medicine Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Sustained-release Medicine Market Size by Type
- 11.2.1 South America, Middle East & Africa Sustained-release Medicine Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Sustained-release Medicine Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Sustained-release Medicine Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Sustained-release Medicine Market Size by Application
- 11.3.1 South America, Middle East & Africa Sustained-release Medicine Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Sustained-release Medicine Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Sustained-release Medicine Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Sustained-release Medicine Market Size by Country
- 11.4.1 South America, Middle East & Africa Sustained-release Medicine Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Sustained-release Medicine Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Sustained-release Medicine Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Sustained-release Medicine Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst